Militello Capital said Wednesday it sold Veenome to Integral Ad Science. Financial terms weren’t announced. Veenome, of New York and Fairfax, Virginia, provides video analytics.
Leesburg, VA (PRWEB) April 01, 2015
Militello Capital, a greater Washington, D.C. private equity investment firm, announces the sale of its portfolio company Veenome, a video analytics expert to Integral Ad Science, a global online resource for media buyers and sellers.
The transaction provides a distribution of proceeds to investors in Militello Venture Partners II (MVP II) fund, primarily registered investment advisers (RIAs) on behalf of their high-net-worth clients.
“We are very excited about seeing the investment come full cycle, providing the opportunity to reward our investors who align their investments with entrepreneurs like [founder] Kevin Lanane,” said Matt Brady, Co-founder and Chief Operating Officer of Militello Capital. “Kevin’s laser focus and dedication to building Veenome’s technology were key drivers to its success.”
Militello Capital invested in Veenome three times over the course of the last two years. Veenome was one of 36 investments in MVP II, which closed in early February and whose portfolio companies experienced aggregate revenue growth of 162 percent from Q4 2013 to Q4 2014.
“When we consider investing in technology companies we evaluate the entrepreneur, as well as the intended purpose within its industry,” said Brady. “We are looking for disruptive technologies that are making a positive impact on their industry by improving current processes and creating employment opportunities.”
# # #
About Militello Capital
Militello Capital is a Northern Virginia-based private equity investment manager working exclusively with registered investment advisers (RIAs) who aim to broaden their portfolio allocations to include entrepreneurs and real estate. Militello’s investment philosophy and strategy are based on the principle that today’s wealth is created in the real economy. The firm currently offers RIAs two distinct investment strategies that complement their existing portfolios: direct investments in income-producing commercial real estate and emerging technology venture capital.
The information contained herein should not be construed as personalized investment advice. Investing in venture capital companies involves some degree of risk and may not be suitable for all investors. Information presented herein is subject to change without notice and should not be considered as a solicitation to buy or sell any security. The companies highlighted above are not necessarily the highest performing investments in the fund, but are noted as purchases made to date. The reader should not assume that investments in the companies identified were or will be profitable.